{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:32:04Z","timestamp":1791405124756,"version":"4.3.3"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6,19]]},"DOI":"10.1097\/qad.0b013e3283480144","type":"journal-article","created":{"date-parts":[[2011,4,22]],"date-time":"2011-04-22T02:55:50Z","timestamp":1303440950000},"page":"1333-1336","source":"Crossref","is-referenced-by-count":33,"title":["Treatment of acute hepatitis C virus infection in HIV-infected MSM: the effect of treatment duration"],"prefix":"10.1097","volume":"25","author":[{"given":"Femke AE","family":"Lambers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kees","family":"Brinkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janke","family":"Schinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid JB","family":"Spijkerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Molenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roel A","family":"Coutinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Prins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan TM","family":"van der Meer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210130","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1097\/QAD.0b013e32833c11a5","article-title":"Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection","volume":"24","author":"Van de Laar","year":"2010","journal-title":"AIDS"},{"key":"R2-12-20210130","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"R3-12-20210130","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"key":"R4-12-20210130","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1086\/596770","article-title":"Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis C","volume":"48","author":"Matthews","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R5-12-20210130","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1002\/hep.23959","article-title":"Treatment of acute hepatitis C in human immunodeficiency virus-infected patients: the HEPAIG study","volume":"52","author":"Piroth","year":"2010","journal-title":"Hepatology"},{"key":"R6-12-20210130","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/jac\/dkp385","article-title":"Treatment of acute hepatitis C in HIV infection","volume":"65","author":"Vogel","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"R7-12-20210130","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3851\/IMP1501","article-title":"Treatment of acute HCV infection in HIV-positive patients: experience from a multicentre European cohort","volume":"15","author":"Vogel","year":"2010","journal-title":"Antivir Ther"},{"key":"R8-12-20210130","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/QAD.0b013e328343443b","article-title":"Acute hepatitis C in HIV-infected individuals: recommendations from the European AIDS Treatment Network (NEAT) consensus conference.","volume":"25","year":"2011","journal-title":"AIDS"},{"key":"R9-12-20210130","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":"Diagnosis, management, and treatment of hepatitis C: an update","volume":"49","author":"Ghany","year":"2009","journal-title":"Hepatology"},{"key":"R10-12-20210130","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/QAD.0b013e3281084e4d","article-title":"Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV\u2013HIV International Panel","volume":"21","author":"Soriano","year":"2007","journal-title":"AIDS"},{"key":"R11-12-20210130","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/QAI.0b013e31815ac47d","article-title":"Effect of baseline CD4 cell count on the efficacy and safety of peginterferon Alfa-2a (40KD) plus ribavirin in patients with HIV\/hepatitis C virus coinfection","volume":"47","author":"Opravil","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R12-12-20210130","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/QAD.0b013e32831940a3","article-title":"Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV","volume":"23","author":"Thomson","year":"2009","journal-title":"AIDS"},{"key":"R13-12-20210130","doi-asserted-by":"crossref","first-page":"F23","DOI":"10.1097\/QAD.0b013e3283391d6d","article-title":"Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV\/hepatitis C virus-coinfected patients","volume":"24","author":"Rallon","year":"2010","journal-title":"AIDS"},{"key":"R14-12-20210130","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/hep.23850","article-title":"Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection","volume":"52","author":"Grebely","year":"2010","journal-title":"Hepatology"},{"key":"R15-12-20210130","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1053\/j.gastro.2010.07.005","article-title":"A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice","volume":"139","author":"Tillmann","year":"2010","journal-title":"Gastroenterology"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002030-201106190-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:29:22Z","timestamp":1786044562000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-201106190-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,19]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e3283480144","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6,19]]}}}